Praxis Medica
Sign in
Issue image

More articles from Volume 38, Issue 1, 2010

ROLE OF ENDURANCE TRAINING (CHRONIC STRESS) ON ANTIOXIDANT SYSTEM ADAPTATION

ACTIVITY XANTHINE OXIDOREDUCTASE AND OXIDATIVE STRESS IN PLASMA HYPERTENSIVE AND HEART FAILURE PATIENTS ASSOCIATED WITH AGE-RELATED CATARACT

THE EFFECT OF CHANGE OF LIFESTYLE AND THERAPY OF METFORMIN IN NEWLY DIAGNOSED PATIENTS WITH TYPE 2 DIABETES

SELF-EVÀLUATED HEALTH CONDITION AND LEADING HEALTH PROBLEMS OF THE REFUGEES FROM THE REFUGE CAMPS IN THE NORTH KOSOVO AND METOHIJA

EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS HOSPITALIZED BECAUSE OF CHEMICAL INJURY OF AN EYE

CONNECTION OF TUMOR BUDDING, LYMPHATIC VESSEL INVASION AND LYMPH NODE METASTASIS IN COLORECTAL CARCINOMAS

B. Đerković ,
B. Đerković

Institute of Pathology, Medical faculty Priština , Kosovska Mitrovica , Kosovo*

View authors publications

Search this author on:

PubMed | Google Scholar
M. Vančentović-Mijović ,
M. Vančentović-Mijović

Institute of Pathology, Medical faculty Priština , Kosovska Mitrovica , Kosovo*

View authors publications

Search this author on:

PubMed | Google Scholar
D. Vukićević ,
D. Vukićević

Institute of Pathology, Medical faculty Priština , Kosovska Mitrovica , Kosovo*

View authors publications

Search this author on:

PubMed | Google Scholar
N. Mitić
N. Mitić

Institute of Pathology, Medical faculty Priština , Kosovska Mitrovica , Kosovo*

View authors publications

Search this author on:

PubMed | Google Scholar

Published: 01.01.2010.

Volume 38, Issue 1 (2010)

pp. 77-81;

https://doi.org/10.70949/pramed201001330DJ

Abstract

Tumor budding refers to an isolated cell or a cluster of up to five undifferentiated tumor cells, located in the stroma close to the invasion frontline of a carcinoma. It has been observed that tumor budding invariably precedes both an invasion into the lymphatic vessels surrounding a tumor and the development of metastases in lymphatic nodes. The aim of this paper is to determine the link between tumour budding, lymphatic vessel invasion and presence o lymph node metastasis in colorectal carcinomas. The study involved 92 cases of colon and upper rectum cancers removed at the Trebinje General Hospital and the Medical Centre in Kosovska Mitrovica. High-grade tumour budding was diagnosed in 66 (71.7%) cases, and lowgrade tumour budding in 26 (20.3%) cases. Lymphatic invasion was detected in 63 (68.5%) cases (55 (87.3%) of these cancers showed high-grade tumour budding, while on the other hand 8 (12.7%) had low-grade tumour budding). Lymphonodal metastases were found in 45 (48.9%) cases (of which 36 (80.0%) were high-grade and 9 (20.0%) low-grade incidents). Based on the ÷2-test, it may be concluded that the distribution of tumour budding in relation to lymphatic invasion (p<0.001) is statistically very significant, which was not confirmed in the case of metastases developing in lymphatic nodes (p>0.05). In conclusion, tumour budding is highly linked to lymphatic invasion, which it most probably precedes. 

Keywords

colorectal carcinomas,

tumour budding,

lymphatic invasion

References

1.
Okuyama T, Oya M, Ishikawa H. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma. J Surg Oncol. 83(1):42–7.
2.
Masaki T, Matsuoka H. Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas. J Gastroenterol Hepatol.
3.
Masaki T, Matsuoka H, Sugiyama M. Budding as a useful determinant of the optimal treatment for T1 rectal carcinomas. Hepatogastroenterology. 50:388–91.
4.
Hase K, Shatney C, Mochizuki H. Long-term results of curative resection of “minimally invasive” colorectal cancer. Dis Colon Rectum. 38:19–26.
5.
Kaneko I, Tanaka S. Lymphatic vessel density at the site of deepest penetration as a predictor of lymph node metastasis in submucosal colorectal cancer. Dis Colon Rectum. 50:13–21.
6.
Kazama S, Watanabe T. Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. Br J Cancer. 94:293–8.
7.
Okuyama T, Nakamura T, Yamaguchi M. Budding is useful to select high-risk patients in Stage II well-differentiated or moderately differentiated colon adenocarcinoma. Dis Colon Rectum. 46:1400–6.
8.
Okuyama T, Oya M. Budding (sprouting) as a useful prognostic marker in colorectal mucinous carcinoma. Jpn J Clin Oncol. 32(10):412–6.
9.
Choi H, Park K. Tumor budding as a prognostic marker in stage-III rectal carcinoma. Int J Colorectal Dis. 22(8):863–8.
10.
Park K, Choi H. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis Colon Rectum. 48:1597–602.
11.
Fletcher C. Diagnostic Histopathology of Tumors.
12.
Hase K, Shatney C, Johnson D. Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum. 36:627–35.
13.
Araki Y, Isomoto H, Shirouzu K. Clinicopathological characteristics of colorectal submucosal carcinoma with lymph node metastasis. Kuru me Med J. 40:123–7.
14.
Shinto E, Jass. Differential prognostic significance of morphologic invasive markers in colorectal cancer: Tumor budding and cytoplasmic podia. Dis Colon Rectum. 49:1422–30.
15.
Morodomi T, Isomoto H, Shirouzu K. An index for estimating the probability of lymph node metastasis in rectal cancers: Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer. 63:539–43.
16.
Nabeshima K, Inoue T, Shinano Y. Cohort migration of carcinoma cells: Differentiated colorectal carcinoma cells move as coherent cell clusters or sheets. Histol Histopathol. 14:1183–97.
17.
Hayashida K, Isomoto H, Shirouzu K. A study of invasive colorectal carcinoma with reference mainly to vessel invasion and budding. J Jpn Soc Coloproctol. 40(119).
18.
Broders AC. Squamous-cell epithelioma of the lip: A study of five hundred and thirty-seven cases. J Am Med Assoc. 74:656–64.
19.
Ueno H, Murphy J, Jass. Tumour “budding” as an index to estimate the potential for aggressiveness in rectal cancer. Histopathology. 40:127–32.
20.
Kumar V, Cotran R, Robbins S. Robbins Basic Pathology. :582.

Citation

Copyright

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by
DOAJ
Google Scholar
ERIHPLUS
MIAR I
Crossref